Hematoma Heterogeneity on Noncontrast Computed Tomography Predicts Intracerebral Hematoma Expansion: A Meta-Analysis

被引:7
作者
Zhang, Danfeng [1 ]
Chen, Jigang [1 ]
Guo, Jiaming [2 ]
Jiang, Ying [1 ]
Dong, Yan [1 ]
Chen, Benjamin Ping-Chi [3 ]
Wang, Junyu [1 ]
Hou, Lijun [1 ]
机构
[1] Second Mil Med Univ, Changzheng Hosp, PLA Inst Neurosurg, Shanghai Inst Neurosurg,Dept Neurosurg, Shanghai, Peoples R China
[2] Second Mil Med Univ, Fac Naval Med, Dept Radiat Med, Shanghai, Peoples R China
[3] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA
关键词
Hematoma expansion; Hematoma heterogeneity; Intracerebral hemorrhage; Noncontrast computed tomography; Poor outcome; BLOOD-PRESSURE REDUCTION; ANGIOGRAPHY SPOT SIGN; ACTIVATED FACTOR-VII; BLACK-HOLE SIGN; CONTRAST EXTRAVASATION; DENSITY HETEROGENEITY; BLEND SIGN; HEMORRHAGE; MORTALITY; GROWTH;
D O I
10.1016/j.wneu.2018.03.048
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Hematoma expansion (HE) is independently associated with clinical outcome after intracerebral hemorrhage (ICH). Hematoma heterogeneity on noncontrast computed tomography (NCCT) is reportedly predictive of HE, but conclusions are inconsistent. We sought to clarify the relationship between hematoma heterogeneity and HE by pooling the pertinent publications. METHODS: The Cochrane Library, PubMed, and Embase were searched for related studies examining the correlation of HE with hematoma heterogeneity, and the secondary endpoint was defined as poor outcome. The effect size was odds ratio (OR) with its 95% confidence interval (CI). Results from each study were pooled using a random-effects model. RESULTS: Ten studies were included with a total of 5931 patients and 675 HEs. We detected a statistically significant association between NCCT heterogeneity and HE (OR, 2.55; 95% CI, 1.82-3.56; P < 0.001), while the correlation with poor outcome was nonsignificant (OR, 1.20; 95% CI, 0.94-1.54, P = 0.15). CONCLUSIONS: Our findings indicate that hematoma heterogeneity on NCCT is positively associated with an increased risk of HE. The relationship between hematoma heterogeneity and poor outcome merits evaluation in further prospective studies.
引用
收藏
页码:E663 / E676
页数:14
相关论文
共 46 条
  • [21] ATTENUATION VALUES OF CHRONIC SUBDURAL-HEMATOMA AND SUBDURAL EFFUSION IN CT SCANS
    ITO, H
    MAEDA, M
    UEHARA, T
    YAMAMOTO, S
    TAMURA, M
    TAKASHIMA, T
    [J]. ACTA NEUROCHIRURGICA, 1984, 72 (3-4) : 211 - 217
  • [22] Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage
    Kim, J.
    Smith, A.
    Hemphill, J. C.
    Smith, W. S.
    Lu, Y.
    Dillon, W. P.
    Wintermark, M.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (03) : 520 - 525
  • [23] Black Hole Sign Novel Imaging Marker That Predicts Hematoma Growth in Patients With Intracerebral Hemorrhage
    Li, Qi
    Zhang, Gang
    Xiong, Xin
    Wang, Xing-Chen
    Yang, Wen-Song
    Li, Ke-Wei
    Wei, Xiao
    Xie, Peng
    [J]. STROKE, 2016, 47 (07) : 1777 - 1781
  • [24] Blend Sign on Computed Tomography Novel and Reliable Predictor for Early Hematoma Growth in Patients With Intracerebral Hemorrhage
    Li, Qi
    Zhang, Gang
    Huang, Yuan-Jun
    Dong, Mei-Xue
    Lv, Fa-Jin
    Wei, Xiao
    Chen, Jian-Jun
    Zhang, Li-Juan
    Qin, Xin-Yue
    Xie, Peng
    [J]. STROKE, 2015, 46 (08) : 2119 - 2123
  • [25] Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2700, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299]
  • [26] Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage
    Mayer, Stephan A.
    Brun, Nikolai C.
    Begtrup, Kamilla
    Broderick, Joseph
    Davis, Stephen
    Diringer, Michael N.
    Skolnick, Brett E.
    Steiner, Thorsten
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (20) : 2127 - 2137
  • [27] Recombinant activated factor VII for acute intracerebral hemorrhage - US phase IIA trial
    Mayer, Stephan A.
    Brun, Nikolai C.
    Broderick, Joseph
    Davis, Stephen M.
    Diringer, Michael N.
    Skolnick, Brett E.
    Steiner, Thorsten
    [J]. NEUROCRITICAL CARE, 2006, 4 (03) : 206 - 214
  • [28] Can a Subset of Intracerebral Hemorrhage Patients Benefit From Hemostatic Therapy With Recombinant Activated Factor VII?
    Mayer, Stephan A.
    Davis, Stephen M.
    Skolnick, Brett E.
    Brun, Nikolai C.
    Begtrup, Kamilla
    Broderick, Joseph P.
    Diringer, Michael N.
    Steiner, Thorsten
    [J]. STROKE, 2009, 40 (03) : 833 - 840
  • [29] Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion
    Morotti, Andrea
    Boulouis, Gregoire
    Romero, Javier M.
    Brouwers, H. Bart
    Jessel, Michael J.
    Vashkevich, Anastasia
    Schwab, Kristin
    Afzal, Mohammad Rauf
    Cassarly, Christy
    Greenberg, Steven M.
    Martin, Renee Hebert
    Qureshi, Adnan I.
    Rosand, Jonathan
    Goldstein, Joshua N.
    [J]. NEUROLOGY, 2017, 89 (06) : 548 - 554
  • [30] ATTENUATION MEASUREMENTS OF WHOLE-BLOOD AND BLOOD FRACTIONS IN COMPUTED TOMOGRAPHY
    NEW, PFJ
    ARONOW, S
    [J]. RADIOLOGY, 1976, 121 (03) : 635 - 640